Overview
REGEN is a BPC-157 and TB-500 blend. It is commonly used in injury recovery protocols due to its fast-acting, multi-pathway effects on tendons, ligaments, muscle and bones.
2-4 Delivery (REGEN Ships from BC, Canada)
3rd Party Tested via Testides (see images)
99.78% Purity (Verified)
Endotoxin Tested (Pass)
Heavy Metals Tested (Pass)
The Science
Scientific Breakdown
Promotes tendon, ligament, muscle, and gut repair
Enhances angiogenesis and nitric oxide signaling
Strong anti-inflammatory effects
Supports muscle, nerve, and soft tissue regeneration
Boosts cellular migration and flexibility
Encourages blood vessel formation and systemic healing
Synergistic Benefits
Accelerated healing of tendons, ligaments, and muscles
Reduced inflammation and swelling
Improved blood flow to damaged tissues
Enhanced recovery from injury, surgery, or overtraining
Support for gut integrity and systemic resilience
Who Uses It
Athletes recovering from injury or surgery
Biohackers optimizing performance and recovery
Individuals with chronic inflammation or joint issues
Clinics offering regenerative therapy protocols
FAQ
Is REGEN approved by Health Canada?
Neither BPC-157 or TB-500, the two compounds in REGEN, are approved by Health Canada; however, research and studies show promising potential for future approval.
What exactly is REGEN?
REGEN is a combination peptide product containing BPC-157 (5 mg) and TB-500 (5 mg) in a single vial for a total of 10 mg. BPC-157 (Body Protection Compound) is a synthetic peptide derived from a protective protein found in stomach acid, while TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring peptide in the human body. Combining these peptides creates synergistic healing effects that exceed what either compound achieves alone.
Why combine BPC-157 and TB-500 instead of using them separately?
Combining BPC-157 and TB-500 targets tissue healing through different but complementary mechanisms. BPC-157 primarily enhances angiogenesis (new blood vessel formation), stabilizes growth hormone receptors, and accelerates tendon and ligament healing. TB-500 promotes cell migration to injury sites, reduces inflammation, and improves flexibility of healing tissue. Together, they create faster, more complete recovery than either peptide alone, while simplifying the dosing protocol into a single injection.
Is REGEN the same as taking BPC-157 and TB-500 separately?
REGEN provides the same active compounds as taking BPC-157 and TB-500 separately, but offers practical advantages. The combination eliminates the need for two separate injections, reduces total injection volume, and ensures consistent dosing ratios optimized for synergistic effects. Research suggests the 1:1 ratio in REGEN (5 mg of each) provides optimal healing benefits while maintaining safety profiles established for each individual peptide.
What form does REGEN come in?
REGEN is supplied as lyophilized (freeze-dried) powder in sterile vials containing 10 mg total peptide content (5 mg BPC-157 + 5 mg TB-500).
What are the primary benefits?
REGEN accelerates healing of tendons, ligaments, muscles, and connective tissue injuries. Users report faster recovery from training, reduced joint pain, improved flexibility, and enhanced tissue repair quality. The combination shows particular effectiveness for chronic injuries that have failed to heal properly, overuse injuries in athletes, and post-surgical recovery. Additional benefits include reduced inflammation, improved gut health from BPC-157, and enhanced mobility during recovery phases.
How does it help with injury recovery?
REGEN works through multiple pathways to accelerate injury healing. BPC-157 increases blood flow to damaged areas, stabilizes nitric oxide production, and promotes collagen formation. TB-500 directs stem cells and other repair cells to injury sites, reduces scar tissue formation, and improves tissue flexibility. Together, they create an optimal healing environment that reduces recovery time by 30-50% compared to natural healing in many reported cases.
Can it help with chronic injuries or old injuries?
Yes, REGEN shows particular promise for chronic injuries that have failed previous treatments. The peptides promote remodeling of poorly healed tissue, reduce chronic inflammation, and can restart stalled healing processes. Users with tendinopathies, partial tears, and degenerative joint conditions lasting months or years often report significant improvements within 4-8 weeks. The combination works by addressing underlying healing deficits rather than just masking symptoms.
Does it improve athletic performance?
REGEN indirectly improves athletic performance by reducing recovery time between training sessions, allowing for higher training volume and intensity. Athletes report being able to train harder more frequently without accumulating overuse injuries. The peptides reduce delayed onset muscle soreness (DOMS), accelerate between-workout recovery, and maintain joint health under heavy training loads. Performance improvements stem from enhanced recovery capacity rather than direct performance enhancement.
What types of injuries respond best to REGEN?
REGEN shows strongest effects for soft tissue injuries including tendinitis, ligament sprains, muscle strains, and partial tears. Tennis elbow, rotator cuff issues, Achilles tendinopathy, and knee ligament injuries show particularly good response rates. The combination also helps with bone healing, though effects are less pronounced than for soft tissues. Joint injuries involving cartilage damage show moderate benefits, primarily through reduced inflammation and improved surrounding tissue health.
Can it help with gut health?
Yes, the BPC-157 component in REGEN provides significant gut healing benefits. BPC-157 was originally studied for its ability to heal ulcers, inflammatory bowel conditions, and intestinal damage. Users report improvements in digestive symptoms, reduced bloating, and better nutrient absorption. The peptide protects the gut lining, reduces intestinal inflammation, and accelerates healing of damaged gut tissue. This makes REGEN valuable for athletes with GI issues or anyone recovering from gut inflammation.
How long should REGEN be used?
Typical REGEN protocols run 4-8 weeks for acute injuries, 8-12 weeks for chronic conditions, and 4-6 weeks for athletic recovery and maintenance. Most users see initial improvements within 7-14 days, with continued progress throughout the full protocol. After completing a cycle, take at least 4 weeks off before starting another cycle to prevent receptor downregulation. Some users adopt long-term protocols alternating 6-8 weeks on with 4-6 weeks off for ongoing injury prevention.
Can it be used continuously without breaks?
Extended continuous use beyond 12 weeks may lead to diminishing returns as receptors downregulate. Most experienced users cycle REGEN with 4-6 week breaks between cycles to maintain effectiveness. Some adopt a 5 days on, 2 days off weekly schedule as an alternative to full breaks. For injury treatment, continuous use through complete healing (up to 12 weeks) is reasonable, followed by a break. For maintenance and performance, cycling protocols preserve long-term effectiveness better than year-round use.
How quickly does it start working?
Most users notice initial effects within 7-14 days, with pain reduction being the earliest indicator. Functional improvements like increased range of motion and reduced inflammation typically appear in weeks 2-3. Structural healing of tissues (tendons, ligaments) takes longer, with significant improvements visible on imaging at 4-6 weeks. The timeline varies by injury severity, with acute injuries responding faster than chronic conditions that have been present for months or years.
What results can be expected after 4 weeks?
After 4 weeks at therapeutic doses, most users report 50-70% reduction in pain, significantly improved function, and ability to resume modified training or activities. Acute injuries may be 80-90% healed, while chronic injuries show substantial improvement but often require additional weeks for complete resolution. Joint mobility increases, inflammation decreases noticeably, and tissue quality improves as measured by reduced swelling and improved palpation findings.
How long until complete healing?
Complete healing timelines depend on injury type and severity. Minor strains and mild tendinitis often resolve in 4-6 weeks. Moderate injuries like partial tears or significant sprains typically require 8-12 weeks. Severe chronic conditions may need 12+ weeks plus ongoing maintenance. REGEN significantly accelerates natural healing but cannot instantly repair extensive tissue damage. Most users see 60-80% improvement by week 6-8, with final healing occurring over subsequent weeks.
Will results last after after stopping?
Yes, healing improvements from REGEN persist after discontinuation because the peptides promote actual tissue repair rather than just symptom masking. Once tissues heal properly, they remain healed. However, REGEN does not prevent future injuries, so users returning to activities that caused the original injury risk re-injury if underlying biomechanics or training errors are not addressed. Many athletes use periodic REGEN cycles (4-6 weeks every 4-6 months) for ongoing injury prevention and recovery optimization.
What are the side effects?
REGEN has an excellent safety profile with minimal reported side effects. Most users experience no adverse effects. Occasional reports include temporary fatigue or lethargy (5-10% of users), mild headaches in the first few days of use, slight water retention, or transient flushing at injection sites. These effects are generally mild and resolve within the first week. Serious side effects are extremely rare in research studies and user reports. The peptides have been extensively studied individually with strong safety data.
Is it safe for long-term use?
Based on available research and user experience, REGEN appears safe for cycles up to 12 weeks at standard doses. Longer-term continuous use (6+ months) has less established safety data, though no significant concerns have emerged. The conservative approach involves cycling use (4-12 weeks on, 4-6 weeks off) to prevent potential receptor downregulation and maintain effectiveness. Both BPC-157 and TB-500 have been studied for extended periods individually without serious safety issues emerging.
Who should not use REGEN?
Avoid REGEN if pregnant, breastfeeding, or trying to conceive due to lack of safety data in these populations. People with active cancer or history of cancer within 5 years should avoid use because growth factors and angiogenesis promotion could theoretically affect tumor growth. Those with severe organ dysfunction should consult physicians before use. Anyone under 21 should avoid REGEN unless under medical supervision, as peptide effects on developing bodies are not well studied.
Can it cause cancer or tumor growth?
There is no evidence that REGEN causes cancer. However, because BPC-157 and TB-500 promote angiogenesis (new blood vessel formation) and healing, theoretical concerns exist about providing blood supply to existing tumors. This is why people with active cancer or recent cancer history are advised to avoid use. In healthy individuals without cancer, the peptides promote normal healing processes. No cancer cases have been attributed to these peptides in research or widespread use, but caution is warranted in cancer populations.
Is it suitable for athletes?
Yes, REGEN is widely used by athletes for injury recovery, overuse injury prevention, and training recovery optimization. The combination helps athletes maintain high training volumes without accumulating repetitive stress injuries. Competitive athletes should check their sport’s prohibited substance list, as some athletic organizations prohibit peptide use. For recreational athletes and those not subject to drug testing, REGEN provides significant recovery benefits. The peptides reduce downtime from minor injuries that would otherwise interrupt training.
Can older adults use it?
REGEN is particularly valuable for adults over 40-50 who experience slower natural healing and increased susceptibility to chronic injuries. The peptides compensate for age-related decline in natural healing factors, helping older adults recover from injuries at rates closer to younger individuals.
What is the minimum age to use REGEN?
REGEN is generally considered appropriate for adults 21 and older due to limited safety data in younger populations. Younger individuals typically have excellent natural healing capacity and may not require peptide support. For teenagers and young adults under 21 with severe injuries that have failed conventional treatment, REGEN might be considered under medical supervision. However, the conservative approach is waiting until skeletal maturity and the early 20s when growth plates are fully closed and endocrine systems are mature.
Should beginners start with REGEN or individual peptides?
Beginners benefit from starting with REGEN rather than individual peptides because the combination is pre-mixed at optimal ratios, requires only one injection, and provides synergistic effects. Starting with both peptides together makes it difficult to assess individual responses, but the strong safety profiles of both compounds make this a minor concern. REGEN simplifies the protocol and ensures proper dosing ratios that have proven effective. Users with specific concerns about tolerating peptides might start with BPC-157 alone, then add REGEN later.
Disclaimer
REGEN (BPC-157 & TB-500) is provided exclusively as a reference standard and research material for accredited laboratories and qualified researchers.
It is intended only for properly supervised in vitro experimentation or authorized non-human preclinical research conducted by trained and qualified personnel.
REGEN is not an approved drug, medicine, dietary supplement, or therapeutic agent. It is not recognized or authorized for human or animal use by Health Canada.
All references to published data, proposed mechanisms, or preclinical observations are included solely for scientific and educational discussion. These statements do not imply or establish safety, efficacy, bioavailability, or appropriateness for administration outside of controlled laboratory settings.
Sale is limited to researchers aged 21 years or older. It assumed this product will be used for research or laboratory use only.
Not for human or veterinary application. Not for medical purposes. Red Fox Peptides will not be held liable for misuse.
Medical Review
REGEN scientific content was reviewed for accuracy on 2026-07-19
By Dr. Anders Schultz, MD, FRCPC Edmonton, AB, Canada